title: Approving new drugs.
authors.affiliation: John L. LaMattina is a senior partner at PureTech Health and the former president of Pfizer Global Research and Development. john.lamattina@comcast.net.
authors.forename: John L
authors.initials: JL
authors.lastname: LaMattina
mesh_terms: D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration